Literature DB >> 20063027

Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center.

S Henriet1, F Kaguelidou, P Bidet, M Lorrot, A De Lauzanne, S Dauger, F Angoulvant, J-C Mercier, C Alberti, E Bingen, A Faye.   

Abstract

Invasive group A streptococcal (GAS) infections have a broad and evolving clinical spectrum, associated with various GAS genotypes and/or virulence factors that are only poorly described in children. We aimed to assess the clinical and molecular characteristics of invasive GAS infections in 28 children admitted from 2000 to 2007 at a large French pediatric tertiary care center. The GAS isolates were characterized molecularly by emm-typing and by the determination of the main virulence factors: speA, speB, speC, smeZ-1, ssa, sic, and silC. The median age of the children was 2.9 years. Osteoarticular infection (OAI) was the main clinical manifestation (n=15/28, 53%). emm-1 predominated (n=10/28), followed by emm-12, 3, and 4. No significant correlation was found between emm type and clinical manifestations, but emm-1 predominated in cases of OAI (n=7/15) and was associated with speA, speB, smeZ-1, and sic virulence factor genes. In this pediatric study, we describe a predominance of OAI associated with emm-1 GAS. Further larger international pediatric studies, including host immunity evaluation, are needed in order to better assess the pathogenesis of GAS infection in children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063027     DOI: 10.1007/s10096-009-0854-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.

Authors:  Franz-Josef Schmitz; Andreas Beyer; Emmanuelle Charpentier; Birgitta Henriques Normark; Marc Schade; Ad C Fluit; Dieter Hafner; Rodger Novak
Journal:  J Infect Dis       Date:  2003-11-05       Impact factor: 5.226

2.  Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease.

Authors:  David J McMillan; R G Beiko; R Geffers; Jan Buer; L M Schouls; B J M Vlaminckx; W J B Wannet; K S Sriprakash; G S Chhatwal
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

3.  Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003.

Authors:  B J M Vlaminckx; W van Pelt; L M Schouls; A van Silfhout; E M Mascini; C P Elzenaar; T Fernandes; A Bosman; J F P Schellekens
Journal:  Clin Microbiol Infect       Date:  2005-03       Impact factor: 8.067

4.  Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.

Authors:  S M Lesko; K L O'Brien; B Schwartz; R Vezina; A A Mitchell
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

5.  Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.

Authors:  Alba Rivera; Montserrat Rebollo; Elisenda Miró; Míriam Mateo; Ferran Navarro; Mercé Gurguí; Beatriz Mirelis; Pere Coll
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

6.  Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons.

Authors:  Robert R Tanz; Stanford T Shulman; Virginia D Shortridge; William Kabat; Kathy Kabat; Emily Cederlund; Jason Rippe; Jill Beyer; Stella Doktor; Bernard W Beall
Journal:  Clin Infect Dis       Date:  2004-11-18       Impact factor: 9.079

7.  Epidemiology of severe Streptococcus pyogenes disease in Europe.

Authors:  Theresa L Lamagni; Jessica Darenberg; Bogdan Luca-Harari; Tuula Siljander; Androulla Efstratiou; Birgitta Henriques-Normark; Jaana Vuopio-Varkila; Anne Bouvet; Roberta Creti; Kim Ekelund; Maria Koliou; Ralf René Reinert; Angeliki Stathi; Lenka Strakova; Vasilica Ungureanu; Claes Schalén; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

8.  Clinical and epidemiologic features of invasive group A streptococcal infections in children.

Authors:  Zuber D Mulla
Journal:  Pediatr Int       Date:  2007-06       Impact factor: 1.524

9.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

10.  Risk factors for pediatric invasive group A streptococcal disease.

Authors:  Stephanie H Factor; Orin S Levine; Lee H Harrison; Monica M Farley; Allison McGeer; Tami Skoff; Carolyn Wright; Benjamin Schwartz; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

View more
  2 in total

Review 1.  Current insights in invasive group A streptococcal infections in pediatrics.

Authors:  Anne Filleron; Eric Jeziorski; Anne-Laure Michon; Michel Rodière; Hélène Marchandin
Journal:  Eur J Pediatr       Date:  2012-02-25       Impact factor: 3.183

2.  Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection.

Authors:  Hiroshi Sakata
Journal:  J Infect Chemother       Date:  2013-05-24       Impact factor: 2.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.